CTOs on the Move

CNR Health Care Network

www.cnrhealthcare.org

 
CNR Health Care Network is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Quality Packaging L L C

Quality Packaging L L C is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, NJ. To find more information about Quality Packaging L L C, please visit www.qpsiusa.com

Calypte Biomedical Corporation

Calypte Biomedical Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Portland, OR. To find more information about Calypte Biomedical Corporation, please visit www.calypte.com

Benefit and Risk Management Services

Benefit and Risk Management Services is a Folsom, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NJMHI

NJMHI is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.